BIOCON.BOBIOCON.BOBSE
Loading
Year-over-year earnings per share growth rate
Percentile
P79
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 63.64% |
| Q3 2025 | 153.85% |
| Q2 2025 | -90.97% |
| Q1 2025 | 1271.43% |
| Q4 2024 | 261.54% |
| Q3 2024 | -102.37% |
| Q2 2024 | 385.84% |
| Q1 2024 | -79.45% |
| Q4 2023 | 423.81% |
| Q3 2023 | 25.00% |
| Q2 2023 | -67.82% |
| Q1 2023 | 845.71% |
| Q4 2022 | -189.74% |
| Q3 2022 | -67.77% |
| Q2 2022 | -39.50% |
| Q1 2022 | 27.39% |
| Q4 2021 | 35.34% |
| Q3 2021 | 63.38% |
| Q2 2021 | -66.67% |
| Q1 2021 | 50.00% |
| Q4 2020 | -0.70% |
| Q3 2020 | 13.49% |
| Q2 2020 | 21.15% |
| Q1 2020 | -39.18% |
| Q4 2019 | -6.04% |
| Q3 2019 | 4.60% |
| Q2 2019 | -3.87% |
| Q1 2019 | -1.63% |
| Q4 2018 | -38.67% |
| Q3 2018 | 194.12% |
| Q2 2018 | -8.11% |
| Q1 2018 | 42.31% |
| Q4 2017 | 32.20% |
| Q3 2017 | -14.49% |
| Q2 2017 | -36.11% |
| Q1 2017 | -26.03% |
| Q4 2016 | 16.80% |
| Q3 2016 | -11.97% |
| Q2 2016 | -53.44% |
| Q1 2016 | 246.59% |